Re: Kaiser: Emerging Therapies for Neovascular Age-related Macular Degeneration: Drugs in the Pipeline (Ophthalmology 2013;120:S11-S15)

Jae Il Shin; Jagadeesh Bayry

doi:10.1016/j.ophtha.2013.11.009

Related publications

Article2022

ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization

Qin Yu, Aumreetam Dinabandhu, Xuan Cao, Jaron Castillo Sanchez, Kathleen Jee, Murilo Wendeborn Rodrigues, Chuanyu Guo, Jing Zhang, Jordan Vancel, Deepak Menon, Noore-Sabah Khan, Tao Ma, Stephany Y. Tzeng, Yassine J. Daoud, Jordan J. Green, Gregg L. Friedman, Silvia Montaner, Akrit Sodhi

Article2013

A role for IL-17 in age-related macular degeneration

Jae Il Shin, Jagadeesh Bayry

Article2010

Evidence for the efficacy of PlGF inhibition in age‐related macular degeneration

Sara Van de Veire, Peter Carmeliet, Tine Van Bergen, Lieve Moons, Ingeborg Stalmans

Article2020

Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies

Nahla Jemni-Damer, Atocha Guedan-Duran, María Fuentes-Andion, Nora Serrano-Bengoechea, Nuria Alfageme-Lopez, Félix Armadá-Maresca, Gustavo V. Guinea, José Pérez‐Rigueiro, Francisco J. Rojo, Daniel González‐Nieto, David Kaplan, Fivos Panetsos

Article2010

Evidence for the role of placental growth in the treatment of age-related macular degeneration

Sara Van de Veire, Tine Van Bergen, Stanley A. Vinores, Max Mazzone, Jean–Marie Stassen, Lieve Moons, A. Noël, Ingeborg Stalmans, Peter Carmeliet